Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThere is no such thing as Mounjaro tablets. Mounjaro (tirzepatide) is a once-weekly injection, not an oral medicine — so any listing you find advertising 'Mounjaro tablets' is either mislabelled or worth treating with serious caution. If you are searching for the cost of tirzepatide or a licensed oral GLP-1 weight-loss treatment in the UK, the honest answer is that pricing depends on which medicine, which dose, and exactly what a provider includes in their fee. Mounjaro as a treatment is a prescription-only medicine; a prescriber reviews your health information before any supply can happen, and that clinical step is part of the legitimate price — every time.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is the misconception worth correcting before anything else. Mounjaro contains tirzepatide, and tirzepatide is only available in the UK as a subcutaneous injection, a pre-filled KwikPen you use once a week. There are no Mounjaro tablets. There are no tirzepatide capsules. If you have seen a listing using those words, it almost certainly refers either to a misunderstanding about the product format, or to something that is not what it claims to be.
The oral GLP-1 medicine that is now licensed for weight management in the UK is Wegovy in tablet form, oral semaglutide, approved by the MHRA in June 2026. That is a different active ingredient from tirzepatide. If it is an injection you want to avoid, the weight-loss treatment options available through a UK prescriber now include both injectable and oral routes, and understanding which is clinically right for you is exactly what a consultation is for.
Searching 'Mounjaro tablets price' is understandable, and if you have been looking into what tirzepatide tablets cost compared with the injectable format, that page explains the pricing landscape and why the licensed product is a pen. But the licensed product is a pen, and the price question that follows from that is: what should a legitimate supply cost, and what should that price include?
Since Eli Lilly raised the UK list price for Mounjaro from 1 September 2025, the private market has repriced accordingly. Reported private prices now range from roughly £149 to £375 per monthly pen, varying by dose and provider. The lowest doses carry lower prices; the highest dose (15mg) sits at the top of that range. These figures are widely reported and reflect real market conditions, though providers set their own fees and they shift. A fuller breakdown of Mounjaro pricing by dose covers this in more detail.
What the headline number often does not include: the consultation fee (charged separately by some providers), the prescription fee, delivery charges, and any clinical support after you have placed your first order. Add those up and a low advertised price can become something quite different by checkout. On dose-increase orders especially (where a clinical review of your progress is genuinely required) some providers charge again for the prescriber's time. That is a reasonable cost; what matters is whether it was disclosed at the start.
The price increase context is also worth reading if you transferred from another provider and are trying to make sense of a higher bill than you expected. Lilly's list price rise was significant, and not every provider communicated it clearly in advance.
nume is not the cheapest provider of tirzepatide. That is a deliberate decision, not an oversight. The single price you see covers the consultation, the prescription, the medicine, and free next-working-day delivery, nothing added at the step where you pay. There is no membership to join. Orders are not auto-renewed; every repeat requires a fresh review by one of our GPhC-registered prescribers. You can verify our pharmacy on the GPhC register at registration number 9012878.
A practical note on timing: if you order by midday Monday to Friday and are approved that day, your treatment ships the same afternoon and arrives the next working day via tracked DPD. That matters if payday has just landed, you have a Monday appointment with yourself, or you are ordering before a holiday. The 12pm cut-off is real, and same-day dispatch is subject to clinical approval, but the process moves quickly. Our clinical team is structured specifically to keep that turnaround reliable.
Current treatment pricing, by dose, is shown on the treatment page, not in body copy here, because prices do move and we would rather show you the current figure than print one that is out of date by the time you read it.
For a drug that requires a prescription and clinical oversight, the cheapest listing does not answer the right question. The right question is whether the supply is genuine, whether a qualified prescriber assessed your suitability, and whether you have somewhere to turn if a side effect concerns you. The MHRA has issued repeated warnings about fake weight-loss pens sold online, counterfeit tirzepatide pens have been seized in UK enforcement operations, including a raid on an illicit manufacturing site in 2025. Some fakes have contained substances that cause serious harm. Red flags include sellers who supply without a prescription, prices dramatically below the market range, and 'discount codes' from sources you cannot verify.
The MHRA's Yellow Card scheme accepts reports of both suspect side effects and suspect sellers, worth bookmarking if you are researching where to get treatment. A provider you can check on the GPhC register, whose prescribers you can read about, and whose supply chain runs through licensed UK distributors is not a premium option. It is just what legitimate supply looks like. For a further look at the 5mg cost specifically, questions about how tirzepatide tablet pricing compares with the injectable pen across doses, or guidance on what a 10ml Mounjaro supply costs and what that volume means in practice, those pages go into more detail. When you are ready, start your free consultation and a prescriber will review your information the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.